Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $26.2800 (-0.87%) ($26.0700 - $26.8100) on Wed. Sep. 30, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.11% (three month average) | RSI | 45 | Latest Price | $26.2800(-0.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.3% a day on average for past five trading days. | Weekly Trend | HALO declines -2.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(49%) IWM(48%) IWC(45%) ARKG(41%) | Factors Impacting HALO price | HALO will decline at least -1.055% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-13%) EDOC(-4%) DRIV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.055% (StdDev 2.11%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $20.49(-22.03%) | Inflection Point | Yes | Resistance Level | $27.05 | 5 Day Moving Average | $26.09(0.73%) | 10 Day Moving Average | $26.49(-0.79%) | 20 Day Moving Average | $27.05(-2.85%) | To recent high | -11.2% | To recent low | 2.1% | Market Cap | $3.592b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |